Pancreatic cancer is a leading cause of cancer-related death in the United States. At Penn Medicine, we're attacking this problem from multiple angles. Our team includes nationally-recognized oncologists, scientists, surgeons, gastroenterologists and pathologists, all working together to create personalized treatment plans from the most advanced therapies available, including clinical trials.

Clinical trials are state-of-the-art therapies, such as immunotherapy, that extend pancreatic cancer treatment beyond chemotherapy, surgery and radiation. Our clinical trials are designed to provide what we call “hope for all stages.”

We also offer support for people working through the often scary time following diagnosis. Our team includes a talented nurse navigator to guide patients through every phase of care.

The team at Penn's Pancreatic Cancer Research Center shares one mission: to turn pancreatic cancer into a chronic, treatable illness.
We are pioneers of leading edge, translational research that combines basic science research and clinical investigation, offering the latest clinical trials that are available for all stages of pancreatic cancer. And we take a multidisciplinary approach — integrating medical oncology, surgery, gastroenterology, radiation oncology, and pathology — to deliver comprehensive and personalized options to our patients.

Learn more about pancreatic cancer: [ Ссылка ]
See what Penn's Pancreatic Cancer Program offers: [ Ссылка ]
Find clinical trials for all phases of pancreatic cancer: [ Ссылка ]
Find a pancreatic cancer clinical trial: [ Ссылка ]

#Pancreatic Cancer #Clinical Trial #PennMedicine

свернуть